Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
|
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [1] Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer’s disease diagnosis: a retrospective study in a Belgian academic hospital
    Matthieu Deltombe
    Catherine Fillee
    Vincent van Pesch
    Acta Neurologica Belgica, 2022, 122 : 245 - 247
  • [2] Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
    Pannee, Josef
    Portelius, Erik
    Minthon, Lennart
    Gobom, Johan
    Andreasson, Ulf
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (04) : 651 - 658
  • [3] The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting
    Niemantsverdriet, Ellis
    Ottoy, Julie
    Somers, Charisse
    De Roeck, Ellen
    Struyfs, Hanne
    Soetewey, Femke
    Verhaeghe, Jeroen
    Van den Bossche, Tobi
    Van Mossevelde, Sara
    Goeman, Johan
    De Deyn, Peter Paul
    Marien, Peter
    Versijpt, Jan
    Sleegers, Kristel
    Van Broeckhoven, Christine
    Wyffels, Leonie
    Albert, Adrien
    Ceyssens, Sarah
    Stroobants, Sigrid
    Staelens, Steven
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 561 - 576
  • [4] Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
    Hansson, Oskar
    Lehmann, Sylvain
    Otto, Markus
    Zetterberg, Henrik
    Lewczuk, Piotr
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1) : 1 - 15
  • [5] Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
    Oskar Hansson
    Sylvain Lehmann
    Markus Otto
    Henrik Zetterberg
    Piotr Lewczuk
    Alzheimer's Research & Therapy, 11
  • [6] The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
    Delaby, Constance
    Estelles, Teresa
    Zhu, Nuole
    Arranz, Javier
    Barroeta, Isabel
    Carmona-Iragui, Maria
    Illan-Gala, Ignacio
    Santos-Santos, Miguel Angel
    Altuna, Miren
    Sala, Isabel
    Sanchez-Saudinos, M. Belen
    Videla, Laura
    Valldeneu, Silvia
    Subirana, Andrea
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Lehmann, Sylvain
    Belbin, Olivia
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [7] Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?
    Klafki, Hans-Wolfgang
    Morgado, Barbara
    Wirths, Oliver
    Jahn, Olaf
    Bauer, Chris
    Esselmann, Hermann
    Schuchhardt, Johannes
    Wiltfang, Jens
    FLUIDS AND BARRIERS OF THE CNS, 2022, 19 (01)
  • [8] Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
    Colletti, Tiziana
    Agnello, Luisa
    Spataro, Rossella
    Guccione, Lavinia
    Notaro, Antonietta
    Lo Sasso, Bruna
    Blandino, Valeria
    Graziano, Fabiola
    Gambino, Caterina Maria
    Giglio, Rosaria Vincenza
    Bivona, Giulia
    La Bella, Vincenzo
    Ciaccio, Marcello
    Piccoli, Tommaso
    BRAIN SCIENCES, 2021, 11 (03) : 1 - 10
  • [9] Role of the Aβ1-42/Aβ1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment'
    Monge-Garcia, Victoria
    Llorca-Tolon, Lourdes
    Gasparini-Berenguer, Ruth
    Monge-Argiles, Jose A.
    REVISTA DE NEUROLOGIA, 2021, 72 (11) : 371 - 376
  • [10] A Method for Evaluating the Level of Soluble β-Amyloid(1-40/1-42) in Alzheimer's Disease Based on the Binding of Gelsolin to β-Amyloid Peptides
    Yu, Yanyan
    Zhang, Lin
    Li, Chenglin
    Sun, Xiaoyu
    Tang, Daoquan
    Shi, Guoyue
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (47) : 12832 - 12835
12345